|
|
||||||||
1 Activity during EGF-Induced Proliferation of Corneal Epithelial Cells: Effect of Phosphoinositide-3 Kinase
From the Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta.
PURPOSE. Previously, the authors showed that epidermal growth factor (EGF)
stimulates phospholipase C
1 (PLC
1) and phosphoinositide-3 kinase
(PI3K) activities in confluent rabbit corneal epithelial cells (RCECs).
The purpose of this study was to investigate whether PLC
1 activity
is upregulated during EGF-induced proliferation of RCECs and to
determine whether there is any cross-talk between PLC
1 and PI3K in
these cells.
METHODS. Simian virus (SV)-40immortalized RCECs were cultured in the presence
and absence of EGF and other agents. At prescribed time intervals, the
cultures were terminated and the cells counted. PLC
1 activity in
intact cells was assessed by measuring the production of
[3H]IP3 in
[3H]myoinositol-labeled cells. The in vitro enzyme
activity was assayed using immunoprecipitated PLC
1 and
[3H]PI(4,5)P2 as substrate.
[3H]IP3, the product of PLC
1, was analyzed
by anion-exchange chromatography. The changes in protein content and
level of phosphorylation of PLC
1 were determined by Western
immunoblot analysis, with the appropriate antibodies.
RESULTS. Addition of EGF (50 ng/ml) caused a time-dependent increase in
proliferation of RCECs. The effect of EGF peaked at approximately 36
hours. Under the same experimental conditions, EGF stimulated PLC
1
activity with a time course similar to that of cell proliferation. Data
from Western immunoblot analysis revealed that the EGF-stimulated
PLC
1 activity was due to increased synthesis of the enzyme.
Furthermore, during cell proliferation, tyrosine phosphorylation of
PLC
1 increased in a time-dependent manner that corresponded closely
with the expression of PLC
1. EGF exerted its effects both on cell
proliferation and PLC
1 activation in a dose-dependent manner.
Treatment of the cells with U-73122, a PLC inhibitor, or
myr-GLYRKAMRLRY, a myristoylated PLC
1 inhibitor peptide, caused
attenuation of both the EGF-stimulated cell proliferation and PLC
1
activity. Treatment of the cells with the PI3K inhibitors, wortmannin
or LY294002, caused inhibition of both EGF-stimulated cell
proliferation and PLC
1 activation. Addition of
PI(3,4,5)P3 to the in vitro PLC
1 assay mixture
stimulated the enzyme activity in a dose-dependent manner.
CONCLUSIONS. The data suggest a positive correlation between EGF-stimulated PLC
1
activation and cell proliferation in RCECs. The EGF-stimulated PLC
1
activity was mirrored by increased synthesis and tyrosine
phosphorylation of the enzyme. The data also show that PLC
1
activation and cell proliferation were inhibited by PI3K inhibitors,
suggesting a role for PI3K in EGF-stimulated proliferation of corneal
epithelial cells.
This article has been cited by other articles:
![]() |
Z. Wang, H. Yang, S. D. Tachado, J. E. Capo-Aponte, V. N. Bildin, H. Koziel, and P. S. Reinach Phosphatase-Mediated Crosstalk Control of ERK and p38 MAPK Signaling in Corneal Epithelial Cells Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5267 - 5275. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang, Q. Wen, S. Mergler, H. Yang, Z. Wang, V. N. Bildin, and P. S. Reinach PKC Isoform-Specific Enhancement of Capacitative Calcium Entry in Human Corneal Epithelial Cells. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3989 - 4000. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Li and L. Lu Epidermal Growth Factor-induced Proliferation Requires Down-regulation of Pax6 in Corneal Epithelial Cells J. Biol. Chem., April 1, 2005; 280(13): 12988 - 12995. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Landreville, S. Coulombe, P. Carrier, M. H. Gelb, S. L. Guerin, and C. Salesse Expression of Phospholipases A2 and C in Human Corneal Epithelial Cells Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 3997 - 4003. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |